Plasma concentrations of asymmetric dimethylarginine are increased in patients with type 2 diabetes mellitus

被引：312
|
作者：
Abbasi, F [1 ]
Asagmi, T [1 ]
Cooke, JP [1 ]
Lamendola, C [1 ]
McLaughlin, T [1 ]
Reaven, GM [1 ]
Stuehlinger, M [1 ]
Tsao, PS [1 ]
机构：
[1] Stanford Univ, Med Ctr, Sch Med, Falk CVRC,Div Cardiovasc Med, Stanford, CA 94305 USA
来源：
AMERICAN JOURNAL OF CARDIOLOGY | 2001年 / 88卷 / 10期
关键词：
D O I：
10.1016/S0002-9149(01)02063-X
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Increased risk of coronary heart disease in patients with type 2 diabetes cannot be accounted for by differences in conventional risk factors. This study demonstrates that plasma concentrations of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, are increased in patients with type 2 diabetes, thereby identifying a new and potentially important coronary heart disease risk factor in this patient population.
引用
收藏
页码：1201 / +
页数：4
相关论文
共 50 条
  • [1] Plasma concentrations of asymmetric dimethylagrinine are increased in patients with type 2 diabetes mellitus
    Abbasi, F
    Asagami, T
    Cooke, JP
    Lamendola, C
    McLaughlin, T
    Stuehlinger, MC
    Tsao, PS
    Reaven, GM
    DIABETES, 2001, 50 : A147 - A148
  • [2] Smoking is associated with increased plasma asymmetric dimethylarginine (ADMA) levels in patients with type 2 diabetes mellitus
    Fard, A
    Bryant, TA
    Tuck, CH
    Vest, JA
    Sciacca, R
    Di Tullio, MR
    Chen, NT
    Berglund, L
    Ginsberg, HN
    Homma, S
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (02) : 327A - 327A
  • [3] Uncomplicated type 1 diabetes is associated with increased asymmetric dimethylarginine concentrations
    Altinova, Alev E.
    Arslan, Metin
    Sepici-Dincel, Aylin
    Akturk, Mujde
    Altan, Nilgun
    Toruner, Fusun B.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (05): : 1881 - 1885
  • [4] Metformin treatment lowers asymmetric dimethylarginine concentrations in patients with type 2 diabetes
    Asagami, T
    Abbasi, F
    Stuelinger, M
    Lamendola, C
    McLaughlin, T
    Cooke, JP
    Reaven, GM
    Tsao, PS
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2002, 51 (07): : 843 - 846
  • [5] Asymmetric dimethylarginine and carotid atherosclerosis in Type 2 diabetes mellitus
    Xia, W.
    Shao, Y.
    Wang, Y.
    Wang, X.
    Chi, Y.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2012, 35 (09) : 824 - 827
  • [6] ASYMMETRIC DIMETHYLARGININE AND CAROTID ATHEROSCLEROSIS IN TYPE 2 DIABETES MELLITUS
    Xia Wei
    Qu Xiufen
    HEART, 2010, 96 : A97 - A97
  • [7] Asymmetric dimethylarginine and carotid atherosclerosis in Type 2 diabetes mellitus
    W. Xia
    Y. Shao
    Y. Wang
    X. Wang
    Y. Chi
    Journal of Endocrinological Investigation, 2012, 35 : 824 - 827
  • [8] Circulating asymmetrical dimethylarginine concentrations are increased in patients with type 2 diabetes and albuminuria
    Krzyzanowska, K
    Mittermayer, F
    Shnawa, N
    Hofer, M
    Schnabler, J
    Etmüller, Y
    Kapiotis, S
    Wolzt, M
    Schernthaner, G
    DIABETOLOGIA, 2005, 48 : A380 - A380
  • [9] Effect of vildagliptin add-on treatment to metformin on plasma asymmetric dimethylarginine in type 2 diabetes mellitus patients
    Cakirca, Mustafa
    Karatoprak, Cumali
    Zorlu, Mehmet
    Kiskac, Muharrem
    Kanat, Mustafa
    Cikrikcioglu, Mehmet Ali
    Soysal, Pinar
    Hursitoglu, Mehmet
    Camli, Ahmet Adil
    Erkoc, Reha
    Abdul-Ghani, Muhammad
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2014, 8 : 239 - 243
  • [10] Coronary flow velocity reserve and asymmetric dimethylarginine in patients with type 2 diabetes mellitus
    Kawata, T
    Daimon, M
    Hasegawa, R
    Toyoda, T
    Sekine, T
    Honjyo, S
    Yamamoto, K
    Uchida, D
    Him, T
    Yoshida, K
    Komuro, I
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 211A - 211A
12345